Fenglei Zhang

Shengli, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair.

A novel ligustrazine-based nanodelivery system protects against doxorubicin-induced cardiotoxicity by targeting the SIRT5-DUSP1 axis for mitochondrial repair.

Journal: Journal of nanobiotechnology
Published: May 18, 2025

PDIA3 rs2788, a risk factor for metabolic syndrome, interacted negatively with antihypertensive medications.

PDIA3 rs2788, a risk factor for metabolic syndrome, interacted negatively with antihypertensive medications.

Journal: Scientific reports
Published: January 25, 2025

A study protocol of the rehabilitative efficacy of cardiovascular ultrasound therapy after percutaneous coronary intervention in patients with coronary artery disease: A multicenter, parallel-group, randomized controlled study.

A study protocol of the rehabilitative efficacy of cardiovascular ultrasound therapy after percutaneous coronary intervention in patients with coronary artery disease: A multicenter, parallel-group, randomized controlled study.

Journal: PloS one
Published: January 19, 2025

The Role of Mitochondrial DNA Copy Number in Venous Thromboembolism: Insights from a 2-Sample Mendelian Randomization Study.

The Role of Mitochondrial DNA Copy Number in Venous Thromboembolism: Insights from a 2-Sample Mendelian Randomization Study.

Journal: Annals of vascular surgery
Published: October 03, 2024

Portulaca Oleracea L. Phenolic Amide Methyl (3,4,5-Trimethoxybenzoyl) Valylprolinate Attenuates Diethylhexyl Phthalate-Induced Human Umbilical Vein Endothelial Cells' Inflammation Through NLRP3 and NF-κB Pathways.

Portulaca Oleracea L. Phenolic Amide Methyl (3,4,5-Trimethoxybenzoyl) Valylprolinate Attenuates Diethylhexyl Phthalate-Induced Human Umbilical Vein Endothelial Cells' Inflammation Through NLRP3 and NF-κB Pathways.

Journal: Journal of medicinal food
Published: August 12, 2024

Puerarin inhibits HDAC1-induced oxidative stress disorder by activating JNK pathway and alleviates acrolein-induced atherosclerosis.

Puerarin inhibits HDAC1-induced oxidative stress disorder by activating JNK pathway and alleviates acrolein-induced atherosclerosis.

Journal: Clinics (Sao Paulo, Brazil)
Published: February 29, 2024

Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study.

Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study.

Journal: ESC heart failure
Published: February 23, 2024

Puerarin alleviates acrolein-induced atherosclerosis by activating the MYH9-mediated SIRT1/Nrf2 cascade to inhibit the activation of inflammasome.

Puerarin alleviates acrolein-induced atherosclerosis by activating the MYH9-mediated SIRT1/Nrf2 cascade to inhibit the activation of inflammasome.

Journal: Biotechnology and applied biochemistry
Published: November 28, 2023

Empagliflozin improves cardiac function in rats with chronic heart failure.

Empagliflozin improves cardiac function in rats with chronic heart failure.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 25, 2023

Renal Safety of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials.

Renal Safety of Sacubitril/Valsartan: A Meta-Analysis of Randomized Controlled Trials.

Journal: Journal of cardiovascular pharmacology
Published: July 22, 2022

Circulating miR-19b-3p as a Novel Prognostic Biomarker for Acute Heart Failure.

Circulating miR-19b-3p as a Novel Prognostic Biomarker for Acute Heart Failure.

Journal: Journal of the American Heart Association
Published: October 06, 2021

Relationship of serum Wnt1-inducible signaling pathway protein 1 levels with coronary artery disease and its severity.

Relationship of serum Wnt1-inducible signaling pathway protein 1 levels with coronary artery disease and its severity.

Journal: Coronary artery disease
Published: April 19, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026